US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Metsera Inc.

34.89

+1.905.76%

Post-market: 34.990.1000+0.29%19:52 EDT

Volume:2.06M

Turnover:69.31M

Market Cap:3.67B

PE:-5.92

High:35.15

Open:31.24

Low:31.01

Close:32.99

Loading ...

Overview Company News Filings

Q4 2024 Amneal Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents

Metsera to Present at TD Cowen’s 45th Annual Health Care Conference

Wall Street bullish on Metsera following January IPO on obesity drug pipeline

Why this newly public biotech could become a force in obesity treatments

BofA Securities Initiates Metsera at Buy With $38 Price Target

MT Newswires Live

BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPal

Metsera Initiated at Outperform by Evercore ISI Group

Evercore ISI Initiates Metsera at Outperform

MT Newswires Live

Metsera Initiated at Buy by B of A Securities

BUZZ-U.S. STOCKS ON THE MOVE- Zoom Communications, Home Depot, Civitas Resources

BUZZ-BofA starts coverage on weight-loss drug developer Metsera with 'buy' rating

Metsera initiated with an Outperform at Evercore ISI

Guggenheim Initiates Metsera at Buy With $56 Price Target

MT Newswires Live

Cantor Fitzgerald Initiates Metsera at Overweight

MT Newswires Live

Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW), Metsera, Inc. (MTSR) and Five9 (FIVN)

Metsera, Inc.: Buy Rating Affirmed Due to Innovative Obesity Market Approach and Strong Growth Catalysts

Metsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant Returns

Metsera initiated with a Buy at Guggenheim

Metsera initiated as Early-Stage Biotech at Goldman Sachs

Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MTSR/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MTSR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","market":"US","secType":"STK","nameCN":"Metsera Inc.","latestPrice":34.89,"timestamp":1754078400000,"preClose":32.99,"halted":0,"volume":2061938,"hourTrading":{"tag":"盘后","latestPrice":34.99,"preClose":34.89,"latestTime":"19:52 EDT","volume":3176,"amount":110973.94,"timestamp":1754092346770},"delay":0,"floatShares":64513712,"shares":105055538,"eps":-5.892395,"marketStatus":"Market Closed","change":1.9,"latestTime":"08-01 16:00:00 EDT","open":31.24,"high":35.15,"low":31.01,"amount":69314864.539246,"amplitude":0.125493,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-5.892395,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754294400000},"marketStatusCode":7,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":32.99,"preHourTrading":{"tag":"盘前","latestPrice":31.22,"preClose":32.99,"latestTime":"09:29 EDT","volume":4755,"amount":151575.41079,"timestamp":1754054999999},"postHourTrading":{"tag":"盘后","latestPrice":34.99,"preClose":34.89,"latestTime":"19:52 EDT","volume":3176,"amount":110973.94,"timestamp":1754092346770},"volumeRatio":1.0555522053474646,"impliedVol":1.5073,"impliedVolPercentile":0.7959},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MTSR\",,,,,undefined,":{"symbol":"MTSR","floatShares":64513712,"roa":"-27.09%","roe":"-108.40%","lyrEps":-14.490661,"volumeRatio":1.0555522053474646,"shares":105055538,"dividePrice":0,"high":35.15,"amplitude":0.125493,"preClose":32.99,"low":31.01,"week52Low":12.3,"pbRate":"8.16","week52High":47.4,"institutionHeld":0,"latestPrice":34.89,"eps":-5.892395,"divideRate":0,"volume":2061938,"delay":0,"ttmEps":-5.892395,"open":31.24,"prevYearClose":18,"prevWeekClose":40.47,"prevMonthClose":32.99,"prevQuarterClose":28.45,"fiveDayClose":40.47,"twentyDayClose":29.45,"sixtyDayClose":22.74},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MTSR\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516530651","title":"Q4 2024 Amneal Pharmaceuticals Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2516530651","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516530651?lang=en_us&edition=fundamental","pubTime":"2025-03-01 18:02","pubTimestamp":1740823351,"startTime":"0","endTime":"0","summary":"Chirag Patel; President, Co-Chief Executive Officer, Co-Founder, Director; Amneal Pharmaceuticals Inc.Anastasios Konidaris; Chief Financial Officer, Executive Vice President; Amneal Pharmaceuticals Inc.Joe Renda; Senior Vice President, Chief Commercial Officer-Specialty; Amneal Pharmaceuticals Inc.Jason Daly; Senior Vice President, Chief Legal Officer, Corporate Secretary; Amneal Pharmaceuticals Inc.Thank you, Tony. Good morning, everyone. At Amneal, we're much more than another generics company. We are an American biopharmaceutical company with a track record of excellence in delivering high-quality complex pharmaceuticals at speed and scale. We are a leader in an essential industry, providing millions of patients with access to affordable and innovative medicines. 2024 was an exceptional year where Amneal delivered stellar financial performance with double-digit revenue and adjusted EBITDA growth and reducing net leverage below 4 times. All segments grew revenues double digits. This ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-amneal-pharmaceuticals-inc-100231626.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MTSR"],"gpt_icon":0},{"id":"2514902839","title":"Metsera to Present at TD Cowen’s 45th Annual Health Care Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2514902839","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514902839?lang=en_us&edition=fundamental","pubTime":"2025-02-26 20:00","pubTimestamp":1740571200,"startTime":"0","endTime":"0","summary":"NEW YORK, Feb. 26, 2025  -- Metsera, Inc.  , a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit Bernard, its Chief Executive Officer, will present at TD Cowen’s 45th Annual Health Care Conference on Tuesday, March 4, 2025, from 1:10 – 1:40 p.m. ET.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/metsera-present-td-cowen-45th-120000026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["COWN","BK4585","BK4566","MTSR","BK4127","BK4207","BK4139","TD"],"gpt_icon":0},{"id":"2514043635","title":"Wall Street bullish on Metsera following January IPO on obesity drug pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2514043635","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514043635?lang=en_us&edition=fundamental","pubTime":"2025-02-26 03:04","pubTimestamp":1740510255,"startTime":"0","endTime":"0","summary":"Investing.com --Wall Street analysts initiated coverage on Metsera with bullish outlook given the biotech firm’s differentiated obesity drug pipeline and potential for significant upside. Metsera is also viewed as a potential acquisition target for larger biopharma firms looking to enter the obesity market.Guggenheim rated Metsera a \"Buy\" with a $56 price target on its ultra-long-acting nutrient-stimulating hormone  analog pipeline. The firm sees Metsera’s lead GLP-1 receptor agonist, MET-097i, as a strong contender in the obesity market, with combination potential driving further value. Guggenheim noted that positive data in late 2025 could double the stock’s value over the next 18-24 months.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/wall-street-bullish-metsera-following-190415270.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2514010770","title":"Why this newly public biotech could become a force in obesity treatments","url":"https://stock-news.laohu8.com/highlight/detail?id=2514010770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514010770?lang=en_us&edition=fundamental","pubTime":"2025-02-26 02:42","pubTimestamp":1740508920,"startTime":"0","endTime":"0","summary":"Metsera's GLP-1 peptide has a long half-life, meaning it could be administered once a month. And the company is ready to scale up.There's a new kid on the block when it comes to drug companies developing treatments for obesity, and this one has a clear advantage over rivals.Metsera Inc. , a New York-based biotech that went public on Jan. 31 with some fanfare, has a full portfolio of weight-loss drugs in development, using both the hormones already used in existing treatments, as well as an oral peptide delivery technology, according to Evercore ISI analysts.That's not all. Metsera's GLP-1 peptide also has a long half-life, which could allow for monthly dosing, a more convenient administration system than the current approved drugs, which require weekly injections.\"Between the long half-life of GLP-1 peptide and slightly improved bioavailability in oral tech, Metsera's API math for oral is quite reasonable/doable,\" the analysts wrote.The company has launched a 28-week, double-blind, pla","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OTX.SI","BK4139","BK4588","BK4585","MTSR","BK4599","VKTX","BK4007","AMRX","BK6520","BK6100"],"gpt_icon":0},{"id":"2514006090","title":"BofA Securities Initiates Metsera at Buy With $38 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2514006090","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514006090?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:49","pubTimestamp":1740494941,"startTime":"0","endTime":"0","summary":"Price: 30.26, Change: +0.45, Percent Change: +1.51","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR"],"gpt_icon":0},{"id":"2514097110","title":"BUZZ-U.S. STOCKS ON THE MOVE-  Eli Lilly, Krispy Kreme, PayPal","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097110","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514097110?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493805,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL6N3PG0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AU","YY","NVD3.UK","BKSY","IART","NVD2.UK","HRMY","BBNX","CLF","SNVD.UK","SRE","DNUT","NTRA","DOMH","NVIW.SI","KDP","NVDS.UK","EVER","NIO.SI","02020","PYPL","PLNT","AS","ZM","HD","CHGG","NEM","CAKE","ONVO","CIVI","MTSR","3NVD.UK","LLY","PTLO","CSCO","EVS.SI"],"gpt_icon":1},{"id":"2514099996","title":"Metsera Initiated at Outperform by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2514099996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514099996?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:05","pubTimestamp":1740488700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MTSR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2025 08:05 ET (13:05 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR"],"gpt_icon":0},{"id":"2514962060","title":"Evercore ISI Initiates Metsera at Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2514962060","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514962060?lang=en_us&edition=fundamental","pubTime":"2025-02-25 21:00","pubTimestamp":1740488448,"startTime":"0","endTime":"0","summary":"Evercore ISI Initiates Metsera at Outperform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR"],"gpt_icon":0},{"id":"2514096755","title":"Metsera Initiated at Buy by B of A Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2514096755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514096755?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:50","pubTimestamp":1740487800,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MTSR/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 25, 2025 07:50 ET (12:50 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTSR","BK4139"],"gpt_icon":0},{"id":"2514355093","title":"BUZZ-U.S. STOCKS ON THE MOVE- Zoom Communications, Home Depot, Civitas Resources","url":"https://stock-news.laohu8.com/highlight/detail?id=2514355093","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514355093?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:10","pubTimestamp":1740485423,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Zoom Communications, Home Depot, Civitas ResourcesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL6N3PG0HV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ZM","HD","ANPDY","XPEV","MTSR","NVDS","02015","89888","BK4587","LU0957808578.USD","82020","CIVI","09888","LI","LU0056508442.USD","02020","NVDL","NVIW.SI","NVD3.UK","COIN","AS","EVS.SI","2NVD.UK","NVDU","3NVD.UK","U","LU1548497426.USD","09866","HIMS","DOMH","NVDS.UK","NIO.SI","NVD2.UK","NVDA","BIDU","SNVD.UK","NVDX","EVER","NVDY","09868","LU0043850808.USD","NVDD","MARA","LU1069344957.HKD","RIOT","YY","LU2092627202.USD","IE0004091025.USD","NVD","NIO"],"gpt_icon":1},{"id":"2514060775","title":"BUZZ-BofA starts coverage on weight-loss drug developer Metsera with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060775","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060775?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:49","pubTimestamp":1740484167,"startTime":"0","endTime":"0","summary":"BUZZ-BofA starts coverage on weight-loss drug developer Metsera with 'buy' rating** BofA Global Research starts coverage on weight-loss drug developer Metsera MTSR.O with \"buy\" rating and $38 PT** PT represents a 27.5% upside to stock's last close** MTSR is poised to \"break into the obesity market\", which is projected to reach ~$170 bln by 2030, with a unique combination of both \"oral and injectable platforms\", setting it apart from its peers - brokerage** Company's lead obesity assets, MET-097i and MET-233i, have \"comparatively long half-lives\" and offer a convenient dosing schedule, with no dose changes needed at first, and just monthly injections afterwards, BofA says** MTSR's oral peptide, MET-224o, could have \"bioavailability that is 5-6x higher\" than the currently approved oral peptide, Novo Nordisk's NOVOb.CO Rybelsus - brokerage** Estimates risk-adjusted revenue of $2.1 bln and $2.5 bln by 2040 for MTSR's lead assets MET-097 and MET-097+MET-233, respectively  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG101:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BAC","MTSR"],"gpt_icon":0},{"id":"2514060974","title":"Metsera initiated with an Outperform at Evercore ISI","url":"https://stock-news.laohu8.com/highlight/detail?id=2514060974","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514060974?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:40","pubTimestamp":1740483610,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 programs in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-initiated-with-an-outperform-at-evercore-isi?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-initiated-with-an-outperform-at-evercore-isi?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTSR"],"gpt_icon":0},{"id":"2514677150","title":"Guggenheim Initiates Metsera at Buy With $56 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2514677150","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514677150?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:32","pubTimestamp":1740483151,"startTime":"0","endTime":"0","summary":"Guggenheim Initiates Metsera at Buy With $56 Price Target","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR"],"gpt_icon":0},{"id":"2514632067","title":"Cantor Fitzgerald Initiates Metsera at Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2514632067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514632067?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:23","pubTimestamp":1740482634,"startTime":"0","endTime":"0","summary":"Cantor Fitzgerald Initiates Metsera at Overweight","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MTSR"],"gpt_icon":0},{"id":"2514062676","title":"Analysts Offer Insights on Technology Companies: Palo Alto Networks (PANW), Metsera, Inc. (MTSR) and Five9 (FIVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514062676","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514062676?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:00","pubTimestamp":1740481233,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Technology sector as 3 analysts just weighed in on Palo Alto Networks (PANW – Research Report), Metsera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-palo-alto-networks-panw-metsera-inc-mtsr-and-five9-fivn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-palo-alto-networks-panw-metsera-inc-mtsr-and-five9-fivn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0348723411.USD","IE00BMPRXN33.USD","LU2265009873.SGD","LU2106854487.HKD","BK4588","BK4532","LU1548497426.USD","BK4550","LU1720051017.SGD","LU1861215975.USD","LU2125909759.SGD","LU1974910355.USD","LU2023250843.SGD","BK4598","LU1169590202.USD","BK4023","LU1917777945.USD","LU1989764748.USD","LU1923622291.USD","LU2286300806.USD","LU2023250504.SGD","IE00B19Z9505.USD","BK4581","FIVN","LU0234570918.USD","BK4139","LU1989764664.SGD","LU2357305700.SGD","PANW","IE00B19Z8W00.USD","BK4585","MTSR","LU1861220033.SGD","BK4097","LU1804176565.USD","IE00BMPRXR70.SGD","BK4560","LU1720051108.HKD","LU1169589451.USD","LU2125909916.SGD","IE00B19Z8X17.USD"],"gpt_icon":0},{"id":"2514062618","title":"Metsera, Inc.: Buy Rating Affirmed Due to Innovative Obesity Market Approach and Strong Growth Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2514062618","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514062618?lang=en_us&edition=fundamental","pubTime":"2025-02-25 19:00","pubTimestamp":1740481213,"startTime":"0","endTime":"0","summary":"Metsera, Inc. (MTSR) has received a new Buy rating, initiated by Bank of America Securities analyst, Tim Anderson. Tim Anderson has given his Buy r...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/metsera-inc-buy-rating-affirmed-due-to-innovative-obesity-market-approach-and-strong-growth-catalysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/metsera-inc-buy-rating-affirmed-due-to-innovative-obesity-market-approach-and-strong-growth-catalysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MTSR"],"gpt_icon":0},{"id":"2514406902","title":"Metsera, Inc.: A Promising Buy in the Obesity Market with Potential for Significant Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=2514406902","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514406902?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:16","pubTimestamp":1740478568,"startTime":"0","endTime":"0","summary":"Seamus Fernandez, an analyst from Guggenheim, has initiated a new Buy rating on Metsera, Inc. (MTSR). Seamus Fernandez has given his Buy rating due...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/metsera-inc-a-promising-buy-in-the-obesity-market-with-potential-for-significant-returns?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/metsera-inc-a-promising-buy-in-the-obesity-market-with-potential-for-significant-returns?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2514048069","title":"Metsera initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2514048069","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514048069?lang=en_us&edition=fundamental","pubTime":"2025-02-25 18:15","pubTimestamp":1740478532,"startTime":"0","endTime":"0","summary":"Guggenheim initiated coverage of Metsera (MTSR) with a Buy rating and $56 price target The firm sees a “highly promising multi-billion opportunity”...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-initiated-with-a-buy-at-guggenheim?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MTSR"],"gpt_icon":0},{"id":"2514506511","title":"Metsera initiated as Early-Stage Biotech at Goldman Sachs","url":"https://stock-news.laohu8.com/highlight/detail?id=2514506511","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514506511?lang=en_us&edition=fundamental","pubTime":"2025-02-25 17:31","pubTimestamp":1740475888,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Chris Shibutani initiated coverage of Metsera (MTSR) as an Early-Stage Biotech. Metsera is clinical-stage biopharmaceutical c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metsera-initiated-as-early-stage-biotech-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metsera-initiated-as-early-stage-biotech-at-goldman-sachs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LU2237443382.USD","LU2471134796.USD","BK4127","LU1868836757.USD","BK4504","IE0034235188.USD","LU2471134952.CNY","LU2750360997.AUD","BK4588","LU2471134879.HKD","BK4533","IE00BFXG1179.USD","LU2237438978.USD","IE0004086264.USD","LU1868836914.USD","IE00B19Z3B42.SGD","LU2471134523.USD","LU1868837300.USD","BK4516","IE0002270589.USD","LU2237443465.HKD","LU2750360641.GBP","LU1791807156.HKD","LU2237443895.HKD","IE00BSNM7G36.USD","LU0096364046.USD","LU2237443549.SGD","LU0061475181.USD","LU1668664300.SGD","LU2237443978.SGD","LU2237443622.USD","IE0004091025.USD","LU1868836591.USD","MTSR","BK4552","SSI","IE00B19Z3581.USD","BK4585","BK4550","LU0106831901.USD","LU1868837136.USD"],"gpt_icon":0},{"id":"2512943679","title":"Metsera (MTSR): Among Stocks Insiders Spent The Most Money On Recently","url":"https://stock-news.laohu8.com/highlight/detail?id=2512943679","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512943679?lang=en_us&edition=fundamental","pubTime":"2025-02-20 03:50","pubTimestamp":1739994654,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Stocks Insiders Spent The Most Money On Recently. In this article, we are going to take a look at where Metsera  stands against other stocks insiders spent the most money on recently.As the broader market continues to rise this year, we thought it would be interesting to highlight some stocks that have seen significant insider buying recently. Insiders—such as executives and directors—often have valuable insights into a company’s strategy, plans, and future initiatives. For instance, when a CEO or CFO invests their own money to purchase company shares, it can be seen as a strong vote of confidence in the company’s prospects. When an insider makes a substantial financial commitment, it often signals an even higher level of confidence in the company’s future performance.What are some of the stocks that have seen the most insider investment recently?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/metsera-mtsr-among-stocks-insiders-195054961.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MTSR","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":61,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MTSR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-28","symbol":"MTSR","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1753675200000,"reportTimeType":"post","actualEps":-0.66},{"market":"US","date":"2025-05-12","symbol":"MTSR","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"pre","actualEps":-1.03},{"market":"US","date":"2025-03-26","symbol":"MTSR","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742961600000,"reportTimeType":"pre","actualEps":-3.52}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MTSR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MTSR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1750478400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MTSR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MTSR","date":"2025-08-01","current":-11.259046,"percent":0.702479,"low":-55.8522,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"high":-6.570442,"avg":-13.746534,"sd":5.063178,"marketCap":3465782198},"quantilePoints":[{"date":"2025-02-07","current":-17.973411,"twenty":-17.939327,"median":-17.8882,"eighty":-17.837073,"marketCap":3042628924},{"date":"2025-02-14","current":-18.277736,"twenty":-18.639274,"median":-18.277736,"eighty":-17.958804,"marketCap":3094146515},{"date":"2025-02-21","current":-19.257661,"twenty":-19.263748,"median":-18.612493,"eighty":-17.973411,"marketCap":3260033158},{"date":"2025-02-28","current":-15.222317,"twenty":-19.263748,"median":-18.292952,"eighty":-17.802989,"marketCap":2576909901},{"date":"2025-03-07","current":-16.749262,"twenty":-19.257661,"median":-17.973411,"eighty":-16.634383,"marketCap":2835398748},{"date":"2025-03-14","current":-15.094245,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":2555229332},{"date":"2025-03-21","current":-17.309229,"twenty":-18.72205,"median":-17.732316,"eighty":-15.847091,"marketCap":2930192911},{"date":"2025-03-28","current":-15.074845,"twenty":-18.72205,"median":-17.767653,"eighty":-15.847091,"marketCap":3152557072},{"date":"2025-04-04","current":-10.624224,"twenty":-18.709149,"median":-17.433667,"eighty":-15.417782,"marketCap":2221812131},{"date":"2025-04-11","current":-6.570442,"twenty":-18.612493,"median":-16.926585,"eighty":-14.065167,"marketCap":1374056864},{"date":"2025-04-17","current":-8.815846,"twenty":-18.585291,"median":-16.597864,"eighty":-11.231036,"marketCap":1843631343},{"date":"2025-04-25","current":-10.639294,"twenty":-18.362232,"median":-16.039969,"eighty":-10.465489,"marketCap":2224963638},{"date":"2025-05-02","current":-11.734368,"twenty":-18.283822,"median":-15.629326,"eighty":-9.926993,"marketCap":2453973115},{"date":"2025-05-09","current":-12.437626,"twenty":-18.170614,"median":-15.417782,"eighty":-10.4896,"marketCap":2601043422},{"date":"2025-05-16","current":-10.120836,"twenty":-18.143134,"median":-15.084545,"eighty":-9.926993,"marketCap":2690472328},{"date":"2025-05-23","current":-11.083125,"twenty":-18.007321,"median":-13.673351,"eighty":-10.08689,"marketCap":2946282563},{"date":"2025-05-30","current":-10.903313,"twenty":-17.962456,"median":-12.437626,"eighty":-10.237022,"marketCap":2898482293},{"date":"2025-06-06","current":-11.330119,"twenty":-17.863854,"median":-12.078462,"eighty":-10.380871,"marketCap":3011942274},{"date":"2025-06-13","current":-13.665697,"twenty":-17.760585,"median":-12.111113,"eighty":-10.505751,"marketCap":3632820504},{"date":"2025-06-20","current":-10.950736,"twenty":-17.702451,"median":-12.009847,"eighty":-10.478878,"marketCap":2911088957},{"date":"2025-06-27","current":-11.345927,"twenty":-17.568059,"median":-11.719298,"eighty":-10.542899,"marketCap":3016144495},{"date":"2025-07-03","current":-11.638368,"twenty":-17.408779,"median":-11.681839,"eighty":-10.571353,"marketCap":3093885594},{"date":"2025-07-11","current":-14.388896,"twenty":-17.268165,"median":-11.697647,"eighty":-10.619566,"marketCap":3825072138},{"date":"2025-07-18","current":-17.506951,"twenty":-17.303722,"median":-11.789624,"eighty":-10.623027,"marketCap":4653960333},{"date":"2025-07-25","current":-15.67129,"twenty":-17.246135,"median":-12.009847,"eighty":-10.627238,"marketCap":4165977359},{"date":"2025-08-01","current":-11.259046,"twenty":-17.080186,"median":-12.060267,"eighty":-10.669177,"marketCap":3465782198}],"updateTime":1754273927902}}}